The DIabetic REtinopathy Candesartan Trials (DIRECT) Programme: baseline characteristics
Renin-angiotensin system blockade has been shown to be superior to other antihypertensive therapy in slowing progression of renal disease in diabetic patients, but questions remain regarding diabetic retinopathy. The primary objective of the DIabetic REtinopathy Candesartan Trials (DIRECT) Programme...
| Format: | Article |
|---|---|
| Language: | English |
| Published: |
SAGE Publications
2005-03-01
|
| Series: | Journal of the Renin-Angiotensin-Aldosterone System |
| Online Access: | https://doi.org/10.3317/jraas.2005.003 |